The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
Ending pandemics is a social decision, not scientific. Governments and organizations rely on social, cultural and political considerations to decide when to officially declare the end of a pandemic. Ideally, leaders try to ...
Oct 18, 2023
0
0
A study published in Collegian has shed light on critical areas for improvement in the delivery of palliative care, particularly among rural nurses.
Oct 18, 2023
0
0
German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed.
Oct 16, 2023
0
0
US pharmacy chain Rite Aid filed for bankruptcy Sunday, the company said, after suffering declining sales and legal threats over its alleged involvement in the opioid crisis.
Oct 16, 2023
0
1
The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat COVID-19, the company said Friday.
Oct 14, 2023
0
1
To Jodi Sherman's way of thinking, the Hippocratic Oath's vow of doing no harm includes doing no harm to the planet—particularly when it comes to the sea of single-use plastic flooding the health care industry.
Oct 11, 2023
0
8
Over the last week or so, there has been widespread condemnation of a letter to the editor penned by a retired British anesthetist and published in a U.K. newspaper.
Oct 9, 2023
0
9
US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.
Oct 9, 2023
0
1
Parents of young children in the United States are finding that with day care centers in short supply, or too expensive, more and more of them—mostly mothers—are having to stay at home to look after their kids.
Oct 6, 2023
0
1
